Philip Serlin
Chief Executive Officer bij BIOLINERX LTD.
Vermogen: 13 138 $ op 31-03-2024
Profiel
Philip Adam Serlin is currently the Chief Executive Officer at BioLineRx Ltd.
He previously served as an Independent Director at XWELL, Inc. from 2011 to 2012, an Independent Non-Executive Director at Vascular Biogenics Ltd., and an Independent Director at Purple Biotech Ltd.
from 2013 to 2016.
Additionally, he was the Chief Financial Officer at Tescom Software Systems Testing Ltd.
in 2007 and the Chief Operating & Financial Officer at Kayote Networks, Inc. in 2008.
He also held positions at Brightman Almagor Zohar & Co. and the US Securities & Exchange Commission.
Mr. Serlin holds a graduate degree from George Washington University and an undergraduate degree from Yeshiva University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
BIOLINERX LTD.
0.02% | 15-03-2024 | 171 900 ( 0.02% ) | 13 138 $ | 31-03-2024 |
Actieve functies van Philip Serlin
Bedrijven | Functie | Begin |
---|---|---|
BIOLINERX LTD. | Chief Executive Officer | 10-10-2016 |
Eerdere bekende functies van Philip Serlin
Bedrijven | Functie | Einde |
---|---|---|
PURPLE BIOTECH LTD | Director/Board Member | 01-01-2016 |
XWELL, INC. | Director/Board Member | 19-07-2012 |
Kayote Networks, Inc.
Kayote Networks, Inc. Specialty TelecommunicationsCommunications Kayote Networks, Inc. hosts voice over internet protocol platforms. It offers voice over internet protocol interoperability, security, routing, peering, monitoring and reporting. The company was founded by Baruch Sterman and David Schwartz in 2003 and is headquartered in Passaic, NJ. | Director of Finance/CFO | 01-08-2008 |
Tescom Software Systems Testing Ltd.
Tescom Software Systems Testing Ltd. Information Technology ServicesTechnology Services Tescom Software Systems Testing Ltd planning and execution of projects in the field of software quality assurance, optimization and improvement of processes in IT organizations in a wide range of companies and fields, such as communications, finance and insurance, commerce and industry, high-tech, government, army and security and the pharmaceutical market. The company was founded in 1990 by Ofer Albeck and is headquartered in Givat Savyon, Israel. | Director of Finance/CFO | 01-12-2007 |
US Securities & Exchange Commission | Corporate Officer/Principal | - |
Opleiding van Philip Serlin
George Washington University | Graduate Degree |
Yeshiva University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
BIOLINERX LTD. | Health Technology |
XWELL, INC. | Consumer Services |
PURPLE BIOTECH LTD | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Tescom Software Systems Testing Ltd.
Tescom Software Systems Testing Ltd. Information Technology ServicesTechnology Services Tescom Software Systems Testing Ltd planning and execution of projects in the field of software quality assurance, optimization and improvement of processes in IT organizations in a wide range of companies and fields, such as communications, finance and insurance, commerce and industry, high-tech, government, army and security and the pharmaceutical market. The company was founded in 1990 by Ofer Albeck and is headquartered in Givat Savyon, Israel. | Technology Services |
US Securities & Exchange Commission | Finance |
Kayote Networks, Inc.
Kayote Networks, Inc. Specialty TelecommunicationsCommunications Kayote Networks, Inc. hosts voice over internet protocol platforms. It offers voice over internet protocol interoperability, security, routing, peering, monitoring and reporting. The company was founded by Baruch Sterman and David Schwartz in 2003 and is headquartered in Passaic, NJ. | Communications |
Vascular Biogenics Ltd.
Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
Brightman Almagor Zohar & Co.
Brightman Almagor Zohar & Co. Miscellaneous Commercial ServicesCommercial Services Brightman Almagor Zohar & Co. provides auditing and accounting services to technology, media, telecommunication, real estate, and financial services sectors. The company offers budget control and cost accounting; business planning; transfer pricing; real estate taxation; and audit committee services. The company is headquartered in Tel Aviv, Israel. | Commercial Services |